Dear Friends, Investors & Traders,

Why is Asiabio Directors buying Netx and not Fintec, Mlab, XOX, DGB, VSolar or other shares in which they are also have  Directorships in?

See

NETX

ASIABIO CAPITAL SDN BHD	23-Aug-2019	Acquired	19,000,000	0.000
FINTEC GLOBAL BERHAD	23-Aug-2019	Acquired	19,000,000	0.000
ASIABIO CAPITAL SDN BHD	22-Aug-2019	Acquired	15,000,000	0.000
FINTEC GLOBAL BERHAD	22-Aug-2019	Acquired	15,000,000	0.000
ASIABIO CAPITAL SDN BHD	15-Aug-2019	Acquired	12,000,000	0.000
FINTEC GLOBAL BERHAD	15-Aug-2019	Acquired	12,000,000	0.000
ASIABIO CAPITAL SDN BHD	13-Aug-2019	Acquired	20,000,000	0.000
FINTEC GLOBAL BERHAD	13-Aug-2019	Acquired	20,000,000	0.000
ASIABIO CAPITAL SDN BHD	09-Aug-2019	Acquired	9,000,000	0.000
FINTEC GLOBAL BERHAD	09-Aug-2019	Acquired	9,000,000	0.000
ASIABIO CAPITAL SDN BHD	08-Aug-2019	Acquired	8,000,000	0.000
FINTEC GLOBAL BERHAD	08-Aug-2019	Acquired	8,000,000	0.000
ASIABIO CAPITAL SDN BHD	07-Aug-2019	Acquired	10,000,000	0.000
FINTEC GLOBAL BERHAD	07-Aug-2019	Acquired	10,000,000	0.000
ASIABIO CAPITAL SDN. BHD.	06-Aug-2019	Acquired	10,000,000	0.000
FINTEC GLOBAL BERHAD	06-Aug-2019	Acquired	10,000,000	0.000

AS YOU CAN SEE CLEARLY ASIABIO HAS BOUGHT A TOTAL OF 130 MILLIONS NETX SHARES IN THE OPEN MARKET WITH PRICES RANGING FROM 1.5 SEN TO 2 SEN

ALTHOUGH THE DIRECTORS OF NETX DO NOT OWN NETX SHARES DIRECTLY THEY INVESTED IN NETX THROUGH THEIR HOLDING OF ASIABIO SHARES OR ALSO CALLED FINTEC

SEE

FINTEC/ASIABIO

MR LEUNG KOK KEONG	30-Nov-2016	Acquired	1,000,000	0.000
MR TAN SIK EEK	30-Nov-2016	Acquired	1,000,000	0.000

IF YOU CHECK UP THE MISSION STATEMENT OF ASIABIO YOU WILL NOTICE THAT ASIABIO/FINTEC IS AN INCUBATOR COMPANY LIKE OSKVi ONCE DID

OSKVI FOUNDED & INCUBATED 2 SUCCESSFUL COMPANIES CALLED GREEN PACKET & MTOUCHE. ALTHOUGH OSKVi MADE THE MISTAKE OF SELLING OUT GPACKET TOO EARLY  AT A LOSS AFTER MANY TRYING YEARS. BUT GPACKET IS NOW A SUCCESS

SO IS ASIABIO/FINTEC. AMONG THE COMPANIES ASIABIO TOOK UP POSITION ARE NETX, FOCUS DYNAMIC, VSOLAR, XOX, DGB, MLAB & OTHERS

AND ASIABIO HAS BEEN DOING AN EXCELLENT JOB IN ITS INVESTMENT SO FAR

SEE ITS BALANCE SHEET

See the 4 sen profit made by Asiabio/Fintec

Let's take a deeper look by visiting its balance sheet

The Group's revenue for the period ending 30 June 2019 was RM9.69 million, an increase of RM9.25 million or 2.12x as compared to RM0.44 million in the previous year's corresponding period. The increase in revenue for the quarter was

mainly due to the sale of short term marketable securities.

The Group made a profit before tax of RM24.47 million for the period ending 30 June 2019 as opposed to loss before tax of RM31.57 million in the corresponding period ending 30 June 2018 and the net loss attributable to equity holders was RM24.47 million, an increase of profit of RM56.03 million or 1.78x as compared to the net loss attributable to equity holders of RM31.56 million in previous year's corresponding period. The increase of profit was mainly due to mark-to-market gain in the Group's long term marketable securities.

The Group's investment in marketable securities increased by RM19.74 million or 18.9% to RM124.27 million as at 30 June 2019 as compared to RM104.53 million as at 30 June 2018, which was mainly due to fair value gain on quoted securities

FROM THE ABOVE WE CAN CLEARLY SEE THAT ASIABIO/FINTEC ACTUALLY MADE ITS PROFITS FROM

The increase of profit was mainly due to mark-to-market gain in the Group's long term marketable securities.

IN OTHER WORDS ASIABIO MADE MONIES FROM SHARE INVESTMENTS!!!

THIS LATEST QUARTER REPORT OF NETX WAS FOR APRIL, MAY & JUNE MONTH OF SUCCESSFUL INVESTMENT IN QUOTED SHARES

FROM WHAT SHARES?

GO SEE FOCUS DYNAMIC SHARE PRICE

FOCUS DYNAMICS GROUP BERHAD (0116)

Company Website
Annual Report
General Meetings

SEE HOW ASIOBIO DIRECTORS MADE A CHUN CHUN BUY ON FOCUS AT 13.5 SEN. AND FOCUS UP  177% TO REACH 37.5 SEN (Please don't chase Focus now)

SEE HOW & WHEN  ASIABIO BOUGHT

ASIABIO CAPITAL SDN BHD	13-Jun-2018	Acquired	1,376,500	0.000
FINTEC GLOBAL BERHAD (FORMERLY KNOWN AS ASIA BIOENERGY TECHNOLOGIES BERHAD)	13-Jun-2018	Acquired	1,376,500	0.000
ASIABIO CAPITAL SDN BHD	08-Jun-2018	Acquired	2,343,500	0.000
FINTEC GLOBAL BERHAD (FORMERLY KNOWN AS ASIA BIOENERGY TECHNOLOGIES BERHAD)	08-Jun-2018	Acquired	2,343,500	0.000
ASIABIO CAPITAL SDN BHD	07-Jun-2018	Acquired	3,295,000	0.000
FINTEC GLOBAL BERHAD (FORMERLY KNOWN AS ASIA BIOENERGY TECHNOLOGIES BERHAD)	07-Jun-2018	Acquired	3,295,000

ON JUNE 13TH 2018 ASIABIO BOUGHT FOCUS SHARES FROM OPEN MARKET AT ONLY 13.5 SEN

FOCUS DYNAMIC AT CURRENT PRICE OF 37.5 SEN MEANS IT HAS GAINED 177% ALREADY

NOT BAD AT ALL IN JUST ONE YEAR 4 MONTHS

NOW YOU MUST KNOW ASIABIO BOUGHT 103 MILLIONS NETX SHARES FROM AUGUST 6 TO 23 2019 AS HIGH AS 2 SEN

SHOULD NETX ALSO PERFORM LIKE FOCUS DYNAMIC AT 177% RISE THEN IT WILL BE 5.54 SEN PER SHARE FOR NETX

SURPRISINGLY, ASIABIO DID NOT SELL ITS FOCUS SHARES. SO WILL ASIABIO BE STILL HOLDING NETX SHARES WHEN NETX ALSO EVENTUALLY CROSS 5 SEN?

I THINK SO

WITH NOTHING TO PUSH FOCUS IT CAN STILL GO UP 177% NOW WITH RM21.6 BILLIONS PUSHING NETX CALVIN THINKS IT COULD EASILY MOVE UP TO OUR TARGET PRICE OF 8 SEN EASILY

THINK AHEAD WITH ME NOW

TODAY, ONLY CALVIN IS CALLING FOR A BUY ON NETX AT 2 SEN WITH MANY DOUBTERS ABOUND

WHEN NETX SHARE PRICE FINALLY CROSSES 8 SEN OR EVEN 15 SEN YOU MUST NOT BE SURPRISED THAT OTHER SIFU & GURU WILL STILL ASK YOU TO CHASE 

BY THEN PLEASE BE VERY CAREFUL

BUT FOR NOW JUST BUY WHILE STILL SO CHEAP!!

BEST REGARDS

Calvin Tan Research

Singapore

Please buy or sell after doing your own due diligence